These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15206999)

  • 1. Iohexol contrast medium induces QT prolongation in amiodarone patients.
    Goernig M; Kirmeier T; Krack A; Hartog CS; Figulla HR; Leder U
    Br J Clin Pharmacol; 2004 Jul; 58(1):96-8. PubMed ID: 15206999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events.
    Grimm W; Steder U; Menz V; Hoffmann J; Maisch B
    Clin Cardiol; 1997 Feb; 20(2):107-10. PubMed ID: 9034638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation.
    Schwarz ER; Czer LS; Simsir SA; Kass RM; Trento A
    Cardiovasc J Afr; 2010; 21(2):109-12. PubMed ID: 20532436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T; Shimizu W; Inagaki M; Satomi K; Taguchi A; Kurita T; Suyama K; Aihara N; Sunagawa K; Kamakura S
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):901-9. PubMed ID: 15271008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
    Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
    J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular ectopy and QTc-interval prolongation associated with dronedarone therapy.
    Gonzalez JE; Sauer WH; Krantz MJ
    Pharmacotherapy; 2013 Oct; 33(10):e179-81. PubMed ID: 23836583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
    Mourad A; Stiber JA; Perfect JR; Johnson MD
    J Antimicrob Chemother; 2019 Jan; 74(1):228-233. PubMed ID: 30295798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced T-U fusion.
    Omar HR
    Am J Emerg Med; 2012 Nov; 30(9):2081.e1-2. PubMed ID: 22205017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
    Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes.
    Malik M
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):209-16. PubMed ID: 11915990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
    Schrickel JW; Schwab JO; Yang A; Bielik H; Bitzen A; Lüderitz B; Lewalter T
    Europace; 2006 Jun; 8(6):403-7. PubMed ID: 16687421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent QT prolongation induced by short-term oral amiodarone therapy.
    Astarcioglu MA; Durmuş HI; Sen T; Amasyalı B
    Kardiol Pol; 2014; 72(2):200-1. PubMed ID: 24604507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.